• The Korean Journal of Nuclear Medicine
• /
• v.29 no.3
• /
• pp.350-354
• /
• 1995

한국 원자력 연구소 부설 원자력병원에 설치된 AVF 싸이클로트론을 이용하여 요즈음 핵의학에 널리 사용되는 PET 용 싸이클로트론의 에너지를 검정 할 수 있고 양성자 과잉 핵종인 싸이클로트론 동위원소의 생산 수율에 중요한 변수인 양성자에너지를 탄소에 입사시켜 입사빔의 Range와 에너지를 측정하는 방법을 제시하였다. 본 실험에서 사용된 양성자 빔의 양성자 에너지는 35 MeV와 50 MeV 사이였으며, 탄소 막은 두께 6.3mm, 밀도 $1.712 g/cm^3$를 사용하였다. 탄소 표적물을 $0.9^{\circ}$씩 스텝 모터를 사용하여 회전시킴으로 두께를 변화 시켜 공칭 에너지에 대한 Range를 측정함으로써 입사된 양성자의 에너지를 구하였고 이를 인출반경과 RF주파수를 바탕으로 상대론 적으로 계산된 에너지와 비교하였다.

• Journal of Radiation Protection and Research
• /
• v.15 no.2
• /
• pp.113-122
• /
• 1990

After four years of planning, equipment acquisition, facility construction and beam testing, the KCCH cyclotron facility was put into operation in November1986. Now the KCCH cyclotron(MC-50) has been used for four years in neutron therapy and radioisotope production. Up to December 1989, 179(1852 sessions) patient have undergone neutron therapy. Radioisotope production for nuclear medicine use was started from March 1989 after extensive work to overcome target transport, target melting, beam diagnostic and chemical processing problems. This status report introduces the cyclotron facility, and the experiences of neutron therapy and isotope production with the MC-50 cyclotron. Besides, the operation results and the general troubles of the MC-50 during 1989 are summarized. Total operation time was 1252.5 hours. Four hundred hours were used for neutron therapy of 599 treatment sessions and 832.5 hours for radioisotope production. Total amount of produced raioisotope was 1695 mCi(Ga-67 : 1478mCi, Tl-201 : 107 mCi, I-123 : 25mCi, In-111 : 85mCi). Twenty hours were used for scheduled beam testing. In 1989, 882% of the planned operation were performed on schedule and this rats is improved remarkably compared to 71.0% in 1988.

• The Korean Journal of Nuclear Medicine
• /
• v.35 no.3
• /
• pp.185-191
• /
• 2001

Objectives: Recently, $[methyl-^{11}C]-({\beta}$-Hydroxyethyl)trimethylammonium ($[^{11}C]$choline) Has been discovered to be a very effective tracer in imaging various human tumors using positron omission tomography. Because of the short half-life of C-11, it is very difficult to use in a routine imaging procedure and needs a frequent synthesis of $[^{11}C]$choline. This can be supplemented by the substitution of $[^{11}C]$choline with $[methyl-^{18}F]$fluorocholine. Here, we would like to report ceil uptake and biodistribution of $[^{11}C]$choline and $[^{18}F]$fluorocholine as a basic study. Methods: $[^{11}C]$Choline was prepared by the treatment of $[^{11}C]CH_3I$ with N,N-dimethylaminoethanol and $[^{18}F]$fluorocholine was synthesized from reaction of $CH_2Br[^{18}F]F$ with N,N-dimethylaminoethanol. The radiochemical purity was checked by high performance liquid chromatography (HPLC). The blodistribution of $[^{11}C]$choline and $[^{18}F]$fluorocholine was determined in balb/c mouse at 5 min, 20 min, 40 min and 80 min. The cell uptake was measured using glioma (9L) and colon adenocarcinoma (SW620). Results: The radiochemical purity was more than 98% after purification. In the liver, uptake did not change over time; the uptake was 20%ID/g for $[^{11}C]$choline and 13%ID/g for $[^{18}F]$fluorocholine. In the kidney, radioactivity decreased over time; the uptake was 15%ID/g for $[^{11}C]$choline and 20%ID/g for $[^{18}F]$fluorocholine, 80 min post-injection. The cell uptake of $[^{11}C]$choline was 4.93% for glioma (9L) and 18.69% for colon adenocarcinoma (SW620). For $[^{18}F]$fluorocholine, 1.77% for glioma (9L) and 2.77% for colon adenocarcinoma (SW620). Conclusion: $[^{11}C]$Choline and $[^{18}F]$fluorocholine showed a different cell uptake tendency, depending on cancer cell line.

• The Korean Journal of Nuclear Medicine
• /
• v.34 no.5
• /
• pp.403-409
• /
• 2000

Objectives: Due to the heterogeneous receptor distribution and changes of receptor status over time, the biochemical measurement of estrogen receptor status of biopsy specimens is not sufficient to diagnose breast cancer. As a result, I-123 labeled estradiols have been applied for the diagnosis. The purpose of this study was to develop a suitable radioligand for imaging estrogen receptor-positive human breast tumors. Methods: Among the various estradiol derivatives, $17{\alpha}-[^{123}I]$iodovinyl estradiol ($[^{123}I]$IVE) has been prepared from $17{\alpha}$-ethynyl estradiol. Labeling of $E-17{\alpha}-[^{123}I]$iodovinyl estradiol (E-$[^{123}I]$IVE) was carried out using peracetic acid with $[^{123}I]NaI\;and\;Z-[^{123}I]IVE$ labelling was archived using chloamine-T/HCl solution with $[^{123}I]$NaI. Labeling yield was determined by silica thin-layer chromatography (TLC) and radiochemical purity was measured by high performance liquid chromatography (HPLC). The biodistribution of E-$[^{123}I]$IVE was measured in immature female rats at 60 min, 120 min and 300 min after injection. Results: The labeling yield of two isomers was 92% and 94% ($E-[^{123}I]IVE\;and\;Z-[^{123}I]IVE$, respectively). The radiochemical purity was more than 98% after purification. The highest uptake was observed at 120 min in uterus (3.11% ID/g for E-$[^{123}I]$IVE). Conclusion: These results suggest the possibility of using E-$[^{123}I]$IVE as an imaging agent for the evaluation of the evaluation of the presence of estrogen receptor in patients with breast cancer.

• Journal of Radiation Protection and Research
• /
• v.14 no.2
• /
• pp.45-50
• /
• 1989

Radiation exposure of the personnel in the neutron therapy facility of KCCH cyclotron neutron system is discussed. In neutron therapy room, medical personnel is exposed to photons of the remanent induced radioactivity from the isocentric gantry in which targets and collimators are mounted. The radiation level of the neutron therapy room of KCCH cyclotron was acceptable and it decreased immediately after beam off. Personal exposure measured by individual monitor was far less than permissible level.

• Journal of Radiation Protection and Research
• /
• v.11 no.2
• /
• pp.146-151
• /
• 1986

In this paper, general features and measured results of vacuum pressure on the vacuum system of 50 MeV proton KCCH-cyclotron which was installed in Korea Cancer Center Hospital are described. The vacuum system comprises five subgroups and the operating sequences are automatically controlled by EPROM-programmable controller. In normal operation, the obtained ultimate pressures of vacuum groups were $5{\times}10^{-6}mbar(I,\;II),\;2{\times}10^{-6}mbar(III),\;1.2{\times}10^{-5}mbar(IV),\;1.5{\times}10^{-6}mbar(V)$, respectively. It was confirmed that these pressures was enough to accelerate the 50 MeV-proton beam.

• The Korean Journal of Nuclear Medicine
• /
• v.29 no.1
• /
• pp.1-8
• /
• 1995

• Radiation Oncology Journal
• /
• v.5 no.2
• /
• pp.75-82
• /
• 1987

For evaluation of biological effect of $p^+(50.5MeV)$ Be neutron beam produced by Korea Cancer Center Hospital (KCCH) cyclotron the RBE had been measured in experimental tumor Walker 256 carcinosarcoma as well as normal tissue, mouse intestine and bone marrow, in single and fractionated irradiation. As pilot study, the RBE had been measured for the mouse jejunal crypt cells in single whole body irradiation of which the result was 2.8. The obtained RBE values of TCD 50 of Walker 256 tumor, bone marrow and intestine En single irraiation were 1.9, 1.9 and 1.5 respectively. In fractionated irradiation, the RBE value of tumor Walker 256 was decreased as increasing of fraction number and increased as increaing of fraction size.

• Journal of Radiation Protection and Research
• /
• v.12 no.2
• /
• pp.1-8
• /
• 1987

The relative biological effectiveness has been measured for the biological characterization of $p^+(50.5\;MeV)$ Be neutron of KCCH-Cyclotron prior to clinical application. Measured RBE of mouse jejunal crypt cell in single whole body irradiation was 2.8. This RBE value is changed differently in different biologic systems such as mouse jejunal crypt cells, intestine and bone marrow in different irradiation method, so that in fractionated irradiation RBE is variable to the different fraction size and total dose, and also variable to the number of fractions.

• Proceedings of the KIPE Conference
• /
• 1999.07a
• /
• pp.581-584
• /
• 1999

본 논문에서는 12펄스 위상제어 정류기 및 수동 필터와 능동필터로 구성된 KCCH 싸이클로트론 전자석용 고정밀, 고안정 전류 전원장치를 위한 각 구성 부분의 제어 및 설계 특징은 다음과 같다. 12펄스 싸이리스터 컨버터의 출력전압 제어를 위하여 아날로그 phase-locked oscillator 점호방식과 함께 부하에 비해 빠른 동특성을 가지는 내부 전압제어 루프를 구성하여, 입력전원과 변압기의 불평형에 의해 발생하는 저차고조파를 줄어들게 하였다. LC 수동필터와 MOSFET으로 구성된 능동필터를 직렬로 연결하여 출력전압 리플을 허용치 이하로 낮추었다. 12펄스 컨버터 출력전압 리플의 최대 peak-to-peak값이 0.1% 이하가 되도록 수동필터 값을 설계하였으며 설계과정을 제시하였다. 16bit D/A와 A/D에 의해 디지털로 제어되는 pass bank MOSFET 레귤레이터는 출력리플의 slow drift 제어와 설정치 값의 정확한 제어를 가능하게 한다. 또한 MOSFET는 전압 구동형 소자이며 turn-on 전류 도통 시에 양의 저항계수를 갖기 때문에, 첫째 전류 구동소자에 비해 간단한 구동회로를 가지며, 둘째 소자의 병렬 연결이 용이하다는 이점을 갖는다. 본 논문에서는 전류 전원장치 각 부분의 설계에 대하여 상세한 설계결과를 제시하며, 실험결과를 통하여 제안된 설계방식의 우수한 정적 및 동적 특성을 입증한다.